JOHNSON JOHN 3 SEC Filings

Filed On	Filing
20 Dec 2024	Form 3: Johnson John, Director · Applied Therapeutics, Inc. No securities owned
05 Oct 2021	Form 3: Johnson John, Director · Xeris Biopharma Holdings, Inc. No securities owned
21 Jul 2021	Form 3: Johnson John, Director · AxoGen, Inc. No securities owned
29 Apr 2020	Form 3: Johnson John, Director · Verastem Inc
05 Feb 2018	Form 3: Johnson John, Director · AVEO PHARMACEUTICALS, INC. No securities owned
02 Jan 2018	Form 3: Johnson John, Director · Strongbridge Biopharma plc
15 Dec 2014	Form 3: Johnson John, Director · Sucampo Pharmaceuticals, Inc. No securities owned
02 Dec 2014	Form 3: Johnson John, Director · Ocugen, Inc.
27 Mar 2014	Form 3: Johnson John, Director · PORTOLA PHARMACEUTICALS INC No securities owned
03 Feb 2012	Form 3: Johnson John, Director · MELINTA THERAPEUTICS, INC. /NEW/ Holds 0 shares of None
30 Aug 2011	Form 3: Johnson John, Director · DENDREON CORP No securities owned
01 Apr 2011	Form 3: Johnson John, Director · Ocera Therapeutics, Inc. No securities owned
02 Feb 2011	Form 3: Johnson John, Director · SAVIENT PHARMACEUTICALS INC Holds 230,000 shares of Common Stock, $.01 par value per share
10 Nov 2009	Form 3: Johnson John H, Sr. VP, Oncology Business Unit · Eli Lilly and Company No securities owned
29 Aug 2007	Form 3: Johnson John H, CEO · IMCLONE SYSTEMS INC No securities owned

Comments